Search results
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
- About
Ranked in the top 5% in the Oncology category of the Journal...
- Articles
Articles - Home page | Molecular Cancer
- Submission Guidelines
Make sure you are submitting to the most suitable journal -...
- Editorial Board
Editorial Board - Home page | Molecular Cancer
- Collections
Collections - Home page | Molecular Cancer
- Language Editing Services
Language Editing Services - Home page | Molecular Cancer
- Thymoquinone Attenuates Tumor Growth in Apc Min Mice by Interference With Wnt-signaling
Background Patients with familial adenomatous polyposis...
- Preparing Your Manuscript
Preparing Your Manuscript - Home page | Molecular Cancer
- About
5 dni temu · As an internationally recognized journal, Molecular Cancer is dedicated to the innovation of how basic cancer research drives advances in cancer prevention, ...
Make sure you are submitting to the most suitable journal - Aims and scope. Understand the costs and funding options - Fees and funding. Make sure your manuscript is accurate and readable - Language editing services. Understand the copyright agreement - Copyright.
As an internationally recognized journal, Molecular Cancer is dedicated to the innovation of how basic cancer research drives advances in cancer prevention, diagnostics, and treatment. Ranked in the top 25% in the Oncology category of Journal …
Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and senescence; cell death and survival; chromatin, gene and RNA regulation; DNA damage and repair; genomics; oncogenes and tumor suppressors; and signal ...
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research. The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research. [1]
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms..
